Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-05-30 12:11 pm Purchase |
2023-04-20 | 13G | Stryve Foods, Inc. SNAX |
Laurence W. Lytton | 191,501 9.990% |
191,501 (New Position) |
Filing History |
| 2023-05-22 4:13 pm Purchase |
2023-05-11 | 13G | Rail Vision Ltd. RVSN |
Laurence W. Lytton | 197,500 7.900% |
197,500 (New Position) |
Filing History |
| 2023-05-11 5:06 pm Purchase |
2023-05-02 | 13G | Miromatrix Medical Inc. MIRO |
Laurence W. Lytton | 1,380,367 5.100% |
1,380,367 (New Position) |
Filing History |
| 2023-03-07 5:22 pm Sale |
2022-12-31 | 13G | Scientific Industries, Inc. SCND |
Laurence W. Lytton | 394,679 5.500% |
-195,529 (-33.13%) |
Filing History |
| 2023-02-22 1:40 pm Purchase |
2023-02-09 | 13G | aTyr Pharma, Inc. ATYR |
Laurence W. Lytton | 4,440,188 8.700% |
4,440,188 (New Position) |
Filing History |
| 2023-02-13 4:41 pm Purchase |
2022-12-31 | 13G | Duos Technologies Group, Inc. DUOT |
Laurence W. Lytton | 634,025 8.900% |
419,325 (+195.31%) |
Filing History |
| 2023-02-13 4:31 pm Purchase |
2022-12-31 | 13G | Giga-tronics Incorporated GIGA |
Laurence W. Lytton | 603,700 9.990% |
328,749 (+119.57%) |
Filing History |
| 2023-02-13 4:22 pm Purchase |
2022-12-31 | 13G | LiqTech International, Inc. LIQT |
Laurence W. Lytton | 566,679 9.990% |
290,432 (+105.14%) |
Filing History |
| 2023-02-13 4:13 pm Purchase |
2022-12-31 | 13G | Scientific Industries, Inc. SCND |
Laurence W. Lytton | 590,208 8.300% |
181,979 (+44.58%) |
Filing History |
| 2023-02-13 4:03 pm Sale |
2022-12-31 | 13G | TFF Pharmaceuticals, Inc. TFFP |
Laurence W. Lytton | 125,029 8.400% |
-477 (-0.38%) |
Filing History |
| 2023-02-13 3:54 pm Sale |
2022-12-31 | 13G | VERTEX ENERGY INC VTNRQ |
Laurence W. Lytton | 513,330 0.700% |
-3,135,737 (-85.93%) |
Filing History |
| 2023-02-13 3:47 pm Purchase |
2022-12-31 | 13G | Exagen Inc. XGN |
Laurence W. Lytton | 871,181 5.300% |
37,876 (+4.55%) |
Filing History |
| 2023-02-13 3:40 pm Sale |
2022-12-31 | 13G | Paratek Pharmaceuticals, Inc. PRTK |
Laurence W. Lytton | 459,961 0.800% |
-2,750,591 (-85.67%) |
Filing History |
| 2023-02-13 3:33 pm Sale |
2022-12-31 | 13G | HTG Molecular Diagnostics, Inc. HTGM |
Laurence W. Lytton | 0 0.000% |
-6,260,292 (Position Closed) |
Filing History |
| 2023-02-13 3:24 pm Sale |
2022-12-31 | 13G | Apollo Endosurgery, Inc. APEN |
Laurence W. Lytton | 3,403,180 6.700% |
-286,740 (-7.77%) |
Filing History |
| 2023-02-13 3:14 pm Purchase |
2022-12-31 | 13G | Cellectar Biosciences, Inc. CLRB |
Laurence W. Lytton | 482,430 4.990% |
64,651 (+15.47%) |
Filing History |
| 2023-02-13 2:55 pm Sale |
2022-12-31 | 13G | Catalyst Biosciences, Inc. CBIO |
Laurence W. Lytton | 177,822 7.100% |
-294,793 (-62.37%) |
Filing History |
| 2023-02-10 7:02 pm Purchase |
2022-12-31 | 13G | EMCORE Corporation EMKR |
Laurence W. Lytton | 292,327 7.800% |
87,937 (+43.02%) |
Filing History |
| 2023-01-19 6:34 pm Purchase |
2023-01-10 | 13G | BIOLASE, Inc. BIOL |
Laurence W. Lytton | 24,611 9.990% |
24,611 (New Position) |
Filing History |
| 2022-11-23 2:40 pm Purchase |
2022-11-14 | 13G | Exagen Inc. XGN |
Laurence W. Lytton | 833,305 5.100% |
833,305 (New Position) |
Filing History |